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Abstract
Introduction: The aim of the present study was to investigate the impact of the time interval from collapse to
return of spontaneous circulation (CPA-ROSC) in cardiac arrest patients and the types of patients who will benefit
from therapeutic hypothermia.
Methods: Four hundred witnessed adult comatose survivors of out-of-hospital cardiac arrest of cardiac etiology
were enrolled in the study. The favorable neurological outcome was defined as category 1 or 2 on the five-point
Pittsburgh cerebral performance scale at the time of hospital discharge. A matching process based on the
propensity score was performed to equalize potential prognostic factors in the hypothermia and normothermia
groups, and to formulate a balanced 1:1 matched cohort study.
Results: The rate of favorable neurological outcome was higher (P < 0.05) in the hypothermia group (n = 110)
than in the normothermia group in patients with CPA-ROSC of 15 to 20 minutes (64% vs. 17%), 20 to 25 minutes
(70% vs. 8%), 25 to 30 minutes (50% vs. 7%), 35 to 40 minutes (27% vs. 0%) and 40 to 45 minutes (29% vs. 2%). A
similar association was observed in a propensity-matched cohort, but the differences were not significant. There
was no significant difference in the rate of favorable neurological outcome between the hypothermia-matched
group and the normothermia-matched group. In the patients whose CPA-ROSC was greater than 15 minutes,
however, the rate of favorable neurological outcome was higher in the hypothermia-matched group than in the
normothermia-matched group (27% vs. 4%, P < 0.001). In multivariate analysis, the CPA-ROSC was an independent
predictor of favorable neurological outcome (every 1 minute: odds ratio = 0.89, 95% confidence interval = 0.85 to
0.92, P < 0.001).
Conclusions: The CPA-ROSC is an independent predictor of neurological outcome. Therapeutic hypothermia is
more beneficial in comatose survivors of cardiac arrest with CPA-ROSC greater than 15 minutes.
Introduction
Cardiac arrest has a poor prognosis and is a major cause
of unexpected death in developed countries. Despite car-
diopulmonary resuscitation (CPR), only a few patients
fully resume their former lifestyle, mainly because of
anoxic brain injury [1,2]. Mild therapeutic hypothermia
(MTH) improves neurological outcome in comatose sur-
vivors of cardiac arrest [3,4]. Previous studies have
reported that coronary reperfusion therapy with
percutaneous coronary intervention improves outcomes
in out-of-hospital cardiac arrest (OHCA) patients [5-8].
The frequency of MTH is increasing in clinical settings;
however, little is known about the types of patients who
will benefit neurologically from MTH, will be able to
resume their former lifestyle, and should not be treated
with MTH [9].
The time interval from collapse to return of sponta-
neous circulation (ROSC) has been reported to be a
strong independent predictor of neurological outcome
in comatose survivors of cardiac arrest [4,10-14]. We
therefore investigated the impact of the time interval
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treated with and without MTH.
Materials and methods
Study patients
We retrospectively enrolled witnessed adult (>18 years
of age) OHCA patients with cardiac causes transported
to Hiroshima City Hospital, who achieved ROSC and
who were comatose between September 2003 and Janu-
ary 2010. All OHCA patients were treated in accordance
with an advanced cardiac life support protocol, and the
patients who met the criteria for hypothermia treatment
were treated with MTH as reported previously [10].
MTH was fundamentally induced in cardiac arrest
patients with presumed cardiac origin and the following
criteria [15]: age 18 to 79 years, and an estimated inter-
val of less than 15 minutes from collapse to the first
attempt at resuscitation by any person.
Before 2006, an assessment of cardiac arrest compli-
cated by ischemic heart disease was made in patients
treated with and without MTH. In patients with sus-
pected acute coronary syndrome, emergency coronary
angiography or percutaneous coronary intervention, or
both, were subsequently performed. After 2006, routine
emergency coronary angiography was performed in
patients treated with MTH.
The present study was approved by the local ethics
committee on human research and is conducted in
accordance with the guidelines of the Declaration of
Helsinki. All data were collected within the normal daily
care routine in an anonymous fashion. The institutional
review board therefore waived the need for informed
patient consent.
Hypothermia protocol
MTH was induced in comatose survivors using a surface
cooling mattress and the administration of physiological
saline (4°C) as reported previously [10]. Before January
2008, the target temperature was set between 32°C and
34°C (fundamentally, 33°C) and was maintained for 48
hours followed by rewarming at 0.5°C every 12 hours.
After January 2008, the core temperature was main-
tained for 24 hours and rewarming continued for 12
hours.
Data collection
The primary endpoint was a favorable neurological
outcome, which is defined as category 1 (good perfor-
mance) or category 2 (moderate disability) on the five-
point Pittsburgh cerebral performance scale; the other
categories are 3 (severe disability), 4 (vegetative state),
and 5 (death) at the time of hospital discharge [16].
Statistical analysis
Continuous variables are presented as medians (with
interquartile ranges), and categorical variables are pre-
sented as numbers and percentages. Differences between
groups at baseline were analyzed using the Mann-
Whitney U test for continuous variables and a
chi-square test or Fisher’s exact test for categorical vari-
ables as appropriate. The rate of favorable neurological
outcome was plotted against the CPA-ROSC every
5 minutes for patients treated with and without MTH.
We used Fisher’s exact test to access differences in the
rate of favorable neurological outcomes every 5 minutes
between the groups.
To detect favorable neurological outcome, we con-
structed receiver-operating characteristic curves for the
CPA-ROSC.
The threshold for performing MTH was set high early
in the study period. For example, we induced MTH only
in comatose survivors whose initial rhythm indicated
ventricular fibrillation. Because the patients were not
randomly assigned to receive MTH or normothermia,
potential confounding and selection biases were
accounted for by developing a propensity score. The
propensity for MTH or not was determined without
regard to the outcome using a multivariate regression
model. For this model, we chose variables we thought
might increase the propensity for MTH over nor-
mothermia therapy, which included age, Pittsburgh
overall performance category score before cardiac arrest,
initial rhythm, the time interval from collapse to start of
CPR and the CPA-ROSC. This model yielded a concor-
dance statistic of 0.80, which indicated good discrimina-
tion. A propensity score was then calculated from the
logistic equation for each patient, which indicated the
probability that a patient would be treated with MTH.
All study patients were pooled and sorted according to
their propensity scores in the ascending order and a
propensity-matched cohort was formed [17].
A logistic regression model was used to examine the
association between the CPA-ROSC and favorable neu-
rological outcome in an unadjusted model, in a model
adjusted for age, gender, and initial rhythm, and in a
model adjusted for age, gender, Pittsburgh overall per-
formance category score, initial rhythm, time interval
from collapse to start of CPR, hypertension, diabetes
mellitus, history of heart disease, emergency coronary
angiography, primary percutaneous coronary interven-
tion, use of intra-aortic balloon pump, use of extracor-
poreal life support, admission after 2006 and propensity
score.
The JMP statistical package (version 5.0.1 J; SAS Insti-
tute, Cary, NC, USA) and R version 2.9.2 [18] were used
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0.05 was considered statistically significant.
Results
Patient characteristics
A flow diagram of the study patients and their outcomes
is depicted in Figure 1. Witnessed adult comatose survi-
vors of OHCA (n = 400) with cardiac causes were
enrolled in the study. The baseline clinical characteris-
tics, treatment and findings for study patients are shown
in Tables 1 and 2. One hundred and ten patients (28%)
were treated with MTH (hypothermia group) and 290
patients were treated without MTH (normothermia
group). There were many differences in baseline charac-
teristics between these groups. The normothermia
group was in a more severe condition for resuscitation.
Outcomes
The outcomes of the study patients are shown in Table
3. The rate of favorable neurological outcome (39% vs.
14%, P < 0.001) and 30-day survival (48% vs. 16%, P <
0.001) were higher in the hypothermia group than in
the normothermia group. The CPA-ROSC in patients
with a favorable neurological outcome was longer (P <
0.001) in the hypothermia group (median, 22 minutes;
interquartile range, 16 to 32 minutes; mean ± standard
deviation, 25 ± 13 minutes) than in the normothermia
group (median, 11 minutes; interquartile range, 5 to 14
minutes; mean ± standard deviation, 12 ± 8 minutes).
The rate of favorable neurological outcome was
plotted against the CPA-ROSC every 5 minutes (Figure
2). In the hypothermia group, the rate of favorable neu-
rological outcome decreased in a stepwise fashion when
the CPA-ROSC was longer than 25 minutes. In the nor-
mothermia group, the rate of favorable neurological out-
come decreased remarkably when the CPA-ROSC was
longer than 15 minutes, and none of the patients whose
CPA-ROSC was longer than 45 minutes had a favorable
neurological outcome. The rate of favorable neurological
outcome was significantly higher in the hypothermia
group than in the normothermia group in patients with
a CPA-ROSC of 15 to 20 minutes (64% vs. 17%, P <
Figure 1 Flow diagram of study patients and outcomes. ROSC, return of spontaneous circulation.
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Page 3 of 12Table 1 Baseline clinical characteristics of the study patients
Hypothermia group (n =
110)
Normothermia group (n =
290)
P
value
Age (years) 55 (46 to 68) 74 (62 to 83) <0.001
Male gender 90 (82) 177 (61) <0.001
Pittsburgh overall performance category scale before index cardiac arrest <0.001
Category 1 109 (99) 216 (74)
Category 2 1 (1) 62 (21)
Category 3 0 (0) 12 (4)
Category 4 0 (0) 0 (0)
Initial rhythm <0.001
Ventricular fibrillation 64 (58) 41 (14)
Pulseless electrical activity 23 (21) 134 (46)
Asystole 23 (21) 115 (40)
Bystander cardiopulmonary resuscitation 61 (55) 137 (47) 0.14
Time interval from collapse to start of cardiopulmonary resuscitation
(minutes)
6 (1 to 10) 7 (1 to 14) 0.049
Time interval from collapse to return of spontaneous circulation (minutes) 35 (21 to 48) 43 (23 to 56) <0.01
Admission after 2006 83 (75) 169 (58) <0.01
Hypertension 44 (40) 85 (29) 0.04
Diabetes mellitus 29 (26) 47 (16) 0.02
Previous history of heart disease 42 (38) 63 (22) <0.001
Previous history of myocardial infarction 18 (16) 15 (5) <0.001
Previous history of chronic heart failure 16 (15) 27 (9) 0.13
Cause of cardiac arrest
Acute coronary syndrome 46 (41) 56 (19)
Old myocardial infarction 12 (11) 4 (1)
Cardiomyopathy 13 (12) 8 (3)
Spasm of coronary artery 8 (7) 2 (1)
Others 27 (25) 72 (25)
Unknown 4 (4) 148 (51)
Data presented as median (interquartile range) or n (%).
Table 2 In-hospital treatment and findings in the study patients
Hypothermia group (n =
110)
Normothermia group (n =
290)
P
value
Dose of epinephrine (mg) 1 (0 to 3) 1 (0 to 2) 0.54
Emergency coronary angiography 68 (62) 34 (12) <0.001
Primary percutaneous coronary intervention 33 (30) 16 (6) <0.001
Use of intra-aortic balloon pump 65 (59) 22 (8) <0.001
Use of extracorporeal life-support 27 (25) 13 (4) <0.001
Time interval from return of spontaneous circulation to target temperature
(minutes)
149 (104 to 262)
Protocol of duration of cooling/rewarming 24 hours/12 hours 40 (36)
Duration of cooling (hours) 47 (24 to 49)
Duration of rewarming (hours) 47 (17 to 57)
Duration of hospital stay (days) 17 (5 to 29) 1 (1 to 3) <0.001
Cause of death within 30 days
Hemodynamic instability 21 (36) 90 (37)
Withdrawal of intensive therapy 18 (32) 85 (35)
Multiple organ failure 15 (26) 10 (4)
Pneumonia 3 (6) 12 (5)
Other 0 (0) 46 (19)
Data presented as median (interquartile range) or n (%).
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minutes (50% vs. 7%, P = 0.02), 35 to 40 minutes (27%
vs. 0%, P = 0.03) and 40 to 45 minutes (29% vs. 2%, P =
0.049). There was a trend toward a higher rate of favor-
able neurological outcome in the hypothermia group
than in the normothermia group in patients in whom
the CPA-ROSC was 30 to 35 minutes (27% vs. 0%, P =
0.08). The rate of favorable neurological outcome was
similar in patients with a CPA-ROSC less than 15
minutes.
Receiver-operating characteristic curves of the CPA-
ROSC to detect favorable neurological outcome are shown
in Figure 3. The areas under the receiver-operating
characteristic curve were 0.79 (95% confidence interval
(CI) = 0.68 to 0.86) and 0.95 (95% CI = 0.92 to 0.98) in the
hypothermia and normothermia groups, respectively. The
cut-off values for the CPA-ROSC of 29 minutes in
hypothermia group and 15 minutes in the normothermia
group had the highest combined sensitivity and specificity,
with accuracy of 75.4% and 92.8% for identifying favorable
neurological outcomes, respectively (Table 4). A long
CPA-ROSC was associated with more accurate negative
predictive values.
Propensity matched analysis
The propensity score-matching process selected 79
patients from the hypothermia group (hypothermia-M
group) and 79 patients from the normothermia group
(normothermia-M group). The mean ± standard
deviation propensity score was 0.41 ± 0.22 in the
hypothermia-M group and was 0.41 ± 0.22 in the
normothermia-M group (P = 0.94; Figure 4). Propensity-
matched patient characteristics, treatments and out-
comes are presented in Table 5. Baseline characteristics
were similar in the two groups except for emergency
coronary angiography, primary percutaneous coronary
intervention, use of intra-aortic balloon pump and use
of extracorporeal circulation. In patients with a favorable
neurological outcome, the CPA-ROSC was significantly
longer (P <0 . 0 0 1 )i np a t i e n t si nt h eh y p o t h e r m i a - M
group (median, 22 minutes; interquartile range, 16 to 31
minutes; mean ± standard deviation, 25 ± 12 minutes)
than those in the normothermia-M group (median, 10
minutes; interquartile range, 5 to 13 minutes; mean ±
standard deviation, 11 ± 9 minutes).
The rate of favorable neurological outcome was
plotted against the CPA-ROSC every 5 minutes in the
propensity-matched cohort (Figure 5). An association
similar to the full cohort (Figure 2) was observed in the
propensity-matched cohort, but the difference was not
statistically significant and might be caused from the
small sample size of the study. There was no significant
difference in the rate of favorable neurological outcome
between the hypothermia-M group and the normother-
mia-M group in the entire propensity-matched cohort
(30% vs. 29%, P = 0.86). In patients whose CPA-ROSC
was more than 15 minutes, however, the rate of favor-
able neurological outcome was higher in the hypother-
mia-M group than in the normothermia-M group (27%
vs. 4%, P < 0.001).
Predictor of neurological outcome
In the full cohort, we tested the association between the
CPA-ROSC and favorable neurological outcome in mul-
tiple models. In an unadjusted model, there was a signif-
icant association between the CPA-ROSC and favorable
neurological outcome (every 1 minute: odds ratio =
0.90, 95% CI = 0.88 to 0.92, P < 0.001). After adjustment
for age, gender, and initial rhythm, this association was
still significant (odds ratio = 0.89, 95% CI = 0.86 to 0.92,
P < 0.001). Finally, after adjustment for all of the above-
mentioned variables, the association between the CPA-
ROSC and favorable neurological outcome remained
significant (odds ratio = 0.89, 95% CI = 0.85 to 0.92, P <
0.001).
Discussion
We showed that the CPA-ROSC is a strong independent
predictor of favorable neurological outcome in the pre-
sent MTH era, and that MTH prolongs the maximum
CPA-ROSC to obtain a favorable neurological outcome.
MTH is more beneficial in OHCA patients with a CPA-
ROSC longer than 15 minutes in terms of neurological
outcome.
Table 3 Outcomes
Hypothermia group (n = 110) Normothermia group (n = 290)
Favorable neurological outcome 43 (39) 40 (14)
Good cerebral performance 42 (38) 39 (13)
Moderate cerebral disability 1 (1) 1 (1)
Severe cerebral disability 0 (0) 1 (1)
Coma or vegetative state 8 (7) 8 (3)
Dead 59 (54) 241 (82)
Thirty-day survival 53 (48) 47 (16)
Data presented as n (%).
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Page 5 of 12Figure 2 Rate of favorable neurological outcome. The rate of favorable neurological outcome (FR) by the time interval from collapse to
return of spontaneous circulation (CPA-ROSC) every 5 minutes in (a) the hypothermia group and (b) the normothermia group. *The rate of FR
in the hypothermia group was higher than that in the normothermia group (P < 0.05).
†There was a trend toward a higher rate of FR in the
hypothermia group than in the normothermia group (0.05 <P < 0.10).
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Page 6 of 12Figure 3 Time interval from collapse to return of spontaneous circulation predicting favorable neurological outcome.R e c e i v e r -
operating characteristic curves for predicting a favorable neurological outcome in (a) the hypothermia group and (b) the normothermia group.
CPA-ROSC, time interval from collapse to return of spontaneous circulation.
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metabolism of organs in cardiac arrest patients, despite
chest compression, the organs experience ischemic
damage from the time of collapse to ROSC [19].
Furthermore, cardiac arrest triggers neuronal death and
inflammation, as well as mitochondrial dysfunction, oxi-
dative stress, altered signal transduction and pro-
grammed cell death, which are implicated in delayed
injury after reperfusion. It has been suggested that the
longer the CPA-ROSC, the greater the damage to
organs, including the brain [20]. We showed that MTH
may protect organs from these delayed injuries. We also
showed that the rate of favorable neurological outcome
in OHCA patients with a CPA-ROSC greater than 15
minutes was terrible, but was extended to 30 minutes or
more in patients treated with hypothermia. MTH may
protect organs from delayed injury, but the no perfusion
or low perfusion state is longer, and damage of organs
may be too severe for patients to return to their former
lifestyle. The metabolic phase of the three-phase model
explains these 15 minutes well [20].
The International Liaison Committee on Resuscitation
has issued guidelines for treatment with MTH [21].
Because of the human resources and costs associated
with MTH, the criteria for treatment are different in
each hospital [3,4,8,10]. The type of patients who can
resume their former lifestyle without MTH has not been
d i s c u s s e d .T h er e s u l t so ft h ep r e s e n ts t u d ys u g g e s tt h a t
MTH may be more beneficial in patients with a CPA-
ROSC greater than 15 minutes and a negative predictive
value of 100% than in those with a CPA-ROSC of 45
minutes in OHCA patients without MTH. We suggest
that comatose survivors of cardiac arrest of cardiac ori-
gin with a CPA-ROSC greater than 15 minutes must be
treated with MTH. On the contrary, the neurological
outcome of patients with a CPA-ROSC less than 15
minutes is likely to be similar with or without MTH.
This does not, however, mean that OCHA patients with
a CPA-ROSC less than 15 minutes should not be trea-
ted with MTH. Our study investigated only the neurolo-
gical outcomes at the time of hospital discharge, and so
performing MTH to protect mild neurological or organ
damage should be permitted.
In our study, the CPA-ROSC of 65 minutes in the
hypothermia group and of 45 minutes in the nor-
mothermia group had a negative predictive value of
100%. These values may be the present points of no
return for CPR in the present clinical settings. Our
study showed that the shorter the CPA-ROSC, the
higher the ratio of favorable neurological outcome. Car-
diac arrest patients should be treated in a manner that
achieves ROSC as soon as possible to obtain a better
outcome.
Study limitations
Our study was not double-blind or randomized and had
the inherent limitations of any single-centre retrospec-
tive investigation. The present study was prone to biases
related to unmeasured factors. We did, however, use
multivariate and propensity analyses to carefully match
patients in an effort to eliminate bias. It was difficult for
us to estimate the time of collapse of cardiac arrest
patients correctly, so we enrolled only the witnessed car-
diac arrest patients in this study. CPR guidelines were
changed during the study period, which might affect the
outcomes. We attempted to adjust for this effect with
the additional covariate of admission after 2006 [12].
Although we found statistically significant differences
Table 4 Cut-off values for CPA-ROSC and diagnostic accuracy
CPA-ROSC Sensitivity Specificity Positive predictive value Negative predictive value Accuracy (%)
Hypothermia group
18 minutes 37 (28 to 46) 91 (86 to 96) 73 (65 to 81) 69 (60 to 78) 70
25 minutes 60 (51 to 69) 84 (77 to 91) 70 (61 to 79) 77 (69 to 85) 74
29 minutes 70 (61 to 79) 79 (71 to 87) 68 (59 to 77) 80 (73 to 87) 75
34 minutes 79 (71 to 87) 70 (61 to 79) 63 (54 to 72) 84 (77 to 91) 74
45 minutes 93 (88 to 98) 40 (31 to 49) 50 (41 to 59) 90 (84 to 96) 61
65 minutes 100 4 (1 to 8) 40 (31 to 49) 100 42
Normothermia group
13 minutes 73 (68 to 78) 95 (92 to 98) 71 (66 to 76) 96 (94 to 98) 92
15 minutes 85 (81 to 89) 94 (91 to 97) 69 (64 to 74) 98 (96 to 99) 93
18 minutes 90 (87 to 93) 91 (88 to 94) 62 (56 to 68) 98 (96 to 99) 91
20 minutes 92 (89 to 95) 88 (84 to 92) 55 (49 to 61) 99 (98 to 99) 89
45 minutes 100 49 (43 to 55) 24 (19 to 29) 100 56
Data presented as mean (95% confidence interval) (%). Time interval from collapse to return of spontaneous circulation (CPA-ROSC) cut-off value of 29 minutes in
the hypothermia group and 15 minutes in the normothermia group had the highest combined sensitivity and specificity, with accuracies of 75.4% and 92.8%,
respectively.
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Page 8 of 12Figure 4 Distribution of propensity scores. Distribution of propensity scores (a) in the hypothermia and normothermia groups and (b) in the
matched hypothermia-M and normothermia-M groups.
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Page 9 of 12between the groups in our main cohort, we found no
statistically significant differences between groups in our
propensity-matched cohort. This difference might be
caused by a sample that was small and may have been
subject to type II error, and by good results for patients
whose CPA-ROSC was less than 5 minutes in the nor-
mothermia-M group with no one whose CPA-ROSC
was less than 5 minutes treated with hypothermia. We
thought that clinical signs, such as neurological findings,
gasping and spontaneous respiration, might be asso-
ciated with the propensity score [22]. Although these
clinical signs should have been recorded at fixed times
after ROSC for proper analysis, we were unable to
retrieve such data from the patients’ medical records.
Conclusions
The CPA-ROSC is an independent predictor of neurolo-
gical outcome in comatose survivors of OHCA. A CPA-
ROSC longer than 15 minutes in the normothermia
therapy group and longer than 30 minutes in the
hypothermia therapy group was associated with low
rates of favorable neurological outcome. MTH prolongs
the CPA-ROSC, which may help comatose survivors of
cardiac arrest obtain favorable neurological outcomes,
Table 5 Patient characteristics and outcomes of propensity-matched patients
Hypothermia-M group (n =
79)
Normothermia-M group (n =
79)
P
value
Age (years) 60 (49 to 72) 61 (50 to 71) 0.62
Male gender 62 (78) 55 (70) 0.20
Pittsburgh overall performance category scale 1 before index cardiac
arrest
78 (99) 79 (100) >0.99
Initial rhythm 0.72
Ventricular fibrillation 23 (29) 25 (32)
Pulseless electrical activity 35 (44) 30 (38)
Asystole 21 (27) 24 (30)
Bystander cardiopulmonary resuscitation 42 (53) 37 (47) 0.43
Time interval from collapse to start of cardiopulmonary resuscitation
(minutes)
8 (1 to 12) 5 (1 to 10) 0.29
Time interval from collapse to return of spontaneous circulation (minutes) 35 (22 to 49) 39 (14 to 50) 0.86
Hypertension 36 (46) 25 (32) 0.07
Diabetes mellitus 23 (29) 16 (20) 0.20
Previous history of heart disease 31 (39) 20 (25) 0.06
Previous history of myocardial infarction 12 (15) 5 (6) 0.07
Previous history of chronic heart failure 12 (15) 9 (11) 0.48
Cause of cardiac arrest
Acute coronary syndrome 35 (44) 20 (25)
Old myocardial infarction 8 (10) 7 (9)
Cardiomyopathy 8 (10) 4 (5)
Spasm of coronary artery 4 (5) 1 (1)
Others 18 (23) 14 (21)
Unknown 6 (8) 33 (42)
Emergency coronary angiography 44 (56) 20 (25) <0.01
Primary percutaneous coronary intervention 23 (29) 9 (11) <0.01
Use of intra-aortic balloon pump 44 (56) 15 (19) <0.001
Use of extracorporeal life-support 21 (27) 5 (6) <0.001
Duration of hospital stay (days) 16 (4 to 27) 1 (0 to 11) <0.001
Favorable neurological outcome 24 (30) 23 (29) 0.86
Good cerebral performance 24 (30) 23 (29)
Coma or vegetative state 6 (8) 1 (1)
Dead 49 (62) 55 (70)
Thirty-day survival 32 (41) 23 (29) 0.13
Data presented as median (interquartile range) or n (%).
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greater than 15 minutes.
Key messages
￿ MTH is more beneficial in patients whose CPA-ROSC is greater than 15
minutes.
￿ Neurological outcome in patients treated with normothermia and
hypothermia were similar in patients with a CPA-ROSC less than 15 minutes.
￿ The CPA-ROSC is an independent predictor of neurological outcome in
comatose survivors of cardiac arrest.
￿ A CPA-ROSC greater than 15 minutes in the normothermia therapy group
and of 30 minutes in the hypothermia therapy group was associated with
low rates of favorable neurological outcome.
Abbreviations
CI: confidence interval; CPA-ROSC: time interval from collapse to return of
spontaneous circulation; CPR: cardiopulmonary resuscitation; MTH: mild
therapeutic hypothermia; OHCA: out-of-hospital cardiac arrest; ROSC: return
of spontaneous circulation.
Figure 5 Rate of favorable neurological outcome in the propensity-matched cohort. Plot representing the rate of favorable neurological
outcome (FR) against the time interval from collapse to return of spontaneous circulation (CPA-ROSC) every 5 minutes in (a) the propensity-
matched hypothermia-M group and (b) the normothermia-M group.
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